Search Within

Karen Lisa Smith

Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
  3. Book Whole (1)
Groups
  1. Breast Medicine Service (11)
  2. Department of Medicine (11)
  3. Solid Tumor Oncology Division (11)
  4. Survivorship Research (11)
  5. Population Sciences Research Program (8)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)

More Groups

People
  1. Clifford Hudis (8)
  2. Mark Robson (8)
  3. Chau Dang (6)
  4. Gabriella D'Andrea-Carlino (6)
  5. Larry Norton (6)
  6. Andrew Seidman (5)

More People

Years
  1. 2008 (1)
  2. 2007 (1)
  3. 2006 (5)
  4. 2005 (5)
Publications
  1. Breast Cancer Research and Treatment (3)
  2. Journal of Clinical Oncology (3)
  3. Clinical Breast Cancer (2)
  4. Clinical Cancer Research (1)
  5. Current Oncology Reports (1)
  6. Expert Opinion on Drug Safety (1)

More Publications

Publishers
  1. Springer (4)
  2. American Society of Clinical Oncology (3)
  3. Elsevier Inc. (2)
  4. American Association for Cancer Research (1)
  5. Informa Healthcare (1)
  6. Mosby Elsevier (1)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save
  • BRCA mutations in women with ductal carcinoma in situ
    Journal Article

    Smith, K. L.; Adank, M.; Kauff, N.; Lafaro, K.; Boyd, J.; Lee, J. B.; Hudis, C.; Offit, K.; Robson, M.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Ductal carcinoma in situ and BRCA mutations: Association and risk factors
    Meeting Abstract

    Smith, K. L.; Adank, M.; Kauff, N.; Lafaro, K.; Boyd, J.; Lee, J.; Hudis, C.; Offit, K.; Robson, M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Norton, L.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Update on hereditary breast cancer
    Journal Article

    Smith, K. L.; Robson, M. E.
    Current Oncology Reports (2006)

    Fulltext@MSK | Save
  • Cardiac dysfunction associated with trastuzumab
    Journal Article

    Smith, K. L.; Dang, C.; Seidman, A. D.
    Expert Opinion on Drug Safety (2006)

    Fulltext@MSK | Save
  • Hematology and oncology pearls
    Book Whole


    Mosby Elsevier (2005)

    Fulltext@MSK | Save
  • Serum peptide profiling (SPP) by mass spectrometry (MS) to identify postmenopausal women with metastatic breast cancer
    Meeting Abstract

    Smith, K. L.; Villanueva, J.; D'Andrea, G.; Moynahan, M. E.; Sklarin, N.; Norton, L.; Hudis, C.; Tempst, P.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save